These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7113965

  • 1. Mitomycin C: phase I study of a constant infusion ambulatory treatment schedule.
    Lokich J, Perri J, Fine N, Bothe A, Nelson T, Greene R, Zipoli T.
    Am J Clin Oncol; 1982 Aug; 5(4):443-7. PubMed ID: 7113965
    [Abstract] [Full Text] [Related]

  • 2. A phase I-II study of continuous 5-day infusion mitomycin-C.
    Yap HY, Valdivieso M, Blumenschein G, Hortobagyi G, Bedikian A.
    Am J Clin Oncol; 1983 Feb; 6(1):109-12. PubMed ID: 6404154
    [Abstract] [Full Text] [Related]

  • 3. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS, Mangalik A, Ferguson J, Elias L.
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [Abstract] [Full Text] [Related]

  • 4. Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.
    Wolff I, Bench K, Beijnen JH, Bruntsch U, Cavalli F, de Jong J, Groot Y, van Tellingen O, Wanders J, Sessa C.
    Clin Cancer Res; 1996 Oct; 2(10):1717-23. PubMed ID: 9816122
    [Abstract] [Full Text] [Related]

  • 5. Protracted ambulatory venous infusion of 5-fluorouracil.
    Lokich J, Fine N, Perri J, Bothe A.
    Am J Clin Oncol; 1983 Feb; 6(1):103-7. PubMed ID: 6837501
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion.
    Lokich JJ.
    Cancer Treat Rep; 1980 Feb; 64(8-9):905-8. PubMed ID: 6256073
    [Abstract] [Full Text] [Related]

  • 7. A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies.
    Villalona-Calero MA, Petit T, Kuhn J, Cobb P, Kraynak M, Eckhardt SG, Drengler R, Simmons C, Santabarbara P, Von Hoff DD, Rowinsky EK.
    Clin Cancer Res; 1999 Nov; 5(11):3369-78. PubMed ID: 10589747
    [Abstract] [Full Text] [Related]

  • 8. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Nov; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 9. Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.
    Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Blum RH, Zeleniuch-Jacquotte A.
    Clin Cancer Res; 1997 Aug; 3(8):1245-52. PubMed ID: 9815806
    [Abstract] [Full Text] [Related]

  • 10. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T, Niitani H, Furue H, Tsukagoshi S, Kanamaru R, Hasegawa K, Akazawa S, Yoneda S, Tominaga T, Sasaki T.
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
    [Abstract] [Full Text] [Related]

  • 11. Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system.
    Lokich J, Bothe A, Zipoli T, Green R, Sonneborn H, Paul S, Philips D.
    J Clin Oncol; 1983 Jan; 1(1):24-8. PubMed ID: 6668481
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of VP-16-213 (Etoposide) administered as a continuous 5-day infusion.
    Lokich J, Corkery J.
    Cancer Treat Rep; 1981 Jan; 65(9-10):887-9. PubMed ID: 7273024
    [Abstract] [Full Text] [Related]

  • 13. Phase I study of high-dose etoposide phosphate in man.
    Fields SZ, Budman DR, Young RR, Kreis W, Ingram R, Schulman P, Cherny RC, Wright J, Behr J, Snow C, Schacter LP.
    Bone Marrow Transplant; 1996 Nov; 18(5):851-6. PubMed ID: 8932836
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase I study of 3-deazauridine in the treatment of adults with solid tumors.
    Stewart DJ, McCredie KD, Barlogie B, Valdivieso M, Benjamin RS, Burgess MA, Bodey GP.
    Cancer Treat Rep; 1980 Nov; 64(12):1295-9. PubMed ID: 7471119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.